Sacituzumab Govitecan in Metastatic Breast Cancer. Reply

N Engl J Med. 2021 Jul 15;385(3):e12. doi: 10.1056/NEJMc2108478.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Breast Neoplasms* / drug therapy
  • Camptothecin / analogs & derivatives
  • Female
  • Humans
  • Immunoconjugates*

Substances

  • Antibodies, Monoclonal, Humanized
  • Immunoconjugates
  • sacituzumab govitecan
  • Camptothecin